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but one of the 12 let-7 family members.
These findings refine the current model of
let-7 regulation by LIN28 and have
important implications for understanding
this pathway in development and
disease.
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Let-7 microRNAs (miRNAs) are critical regulators of
animaldevelopment, stemcell differentiation, glucose
metabolism, and tumorigenesis. Mammalian ge-
nomes contain 12 let-7 isoforms that suppress ex-
pression of a common set of target mRNAs. LIN28
proteins selectively block let-7 biogenesis in undiffer-
entiated cells and in cancer. The current model for
coordinate let-7 repression involves the LIN28 cold-
shock domain (CSD) binding the terminal loop and
the two CCHC-type zinc fingers recognizing a GGAG
sequence motif in precursor let-7 (pre-let-7) RNAs.
Here, we perform a systematic analysis of all let-7
miRNAs and find that a single let-7 family member,
human let-7a-3 (and its murine ortholog let-7c-2),
escapes LIN28-mediated regulation. Mechanistically,
we find that the pre-let-7c-2 loop precludes LIN28A
binding and regulation. These findings refine the cur-
rent model of let-7 regulation by LIN28 proteins and
have important implications for understanding the
LIN28/let-7 axis in development and disease.
INTRODUCTION
Let-7 is one of the most highly conserved microRNAs (miRNAs)
in animals (Pasquinelli et al., 2000; Reinhart et al., 2000). The hu-
man let-7 family comprises 12members that are expressed from
eight different loci (let-7a-1, let-7a-2, let-7a-3, let-7b, let-7c, let-
7d, let-7e, let-7f-1, let-7f-2, let-7g, let-7i, and miR-98) (Roush
and Slack, 2008). Each member is embedded in a let-7 primary
miRNA hairpin (let-7 pri-miRNA or pri-let-7) that is processed
by the DROSHA-DGCR8-containing Microprocessor complex
(Denli et al., 2004; Gregory et al., 2004). This processing gener-
ates 67- to 80-nt-long let-7 precursor miRNA (let-7 pre-miRNAs
or pre-let-7) that can be classified into two groups: group I let-7
pre-miRNAs (let-7a-2, let-7c, and let-7e), which are directly
processed by the Dicer complex in the cytoplasm; and group II
let-7 pre-miRNAs (all the other let-7 members), which undergo
30 mono-uridylation by terminal uridyl transferases (TUTases)
ZCCHC6, ZCCHC11, andGLD2 in order to be efficiently matured260 Cell Reports 13, 260–266, October 13, 2015 ª2015 The Authorsby DICER (Heo et al., 2012). Nearly identical 22-nt-long mature
let-7 miRNAs (namely, let-7-5p) are generated by DICER pro-
cessing and associate with Argonaute proteins in the miRNA-
induced silencing complex (miRISC), where they function by
repressing a broad array of genes involved in the control of
development, cell proliferation, cell growth, metabolism, and
inflammation (B€ussing et al., 2008). These functions of let-7
miRNAs primarily are accomplished in differentiated cells where
they are expressed abundantly.
Let-7 pri- and pre-miRNAs harbor a typical hairpin struc-
ture with a stem containing the let-7-5p miRNA sequence
base paired extensively with the partially complementary let-
7-3p miRNA sequence, connected by a so-called terminal
loop region of variable lengths and structures among different
let-7 family members, a region referred to as pre-element
(preE) (Nam et al., 2011). Let-7 preE serves as a platform to
recruit RNA-binding proteins, such as LIN28, KHSRP (also
known as KSRP), hnRNPA1, and TRIM25, in order to posttran-
scriptionally regulate let-7 biogenesis (Heo et al., 2008; Mi-
chlewski and Ca´ceres, 2010; Newman et al., 2008; Rybak
et al., 2008; Trabucchi et al., 2009; Viswanathan et al., 2008;
Zhang et al., 2015). LIN28 proteins play pervasive roles during
animal development and are often dysregulated in cancer (Am-
bros and Horvitz, 1984; Moss et al., 1997; Moss and Tang,
2003; Shyh-Chang and Daley, 2013; Thornton and Gregory,
2012). The paralogous LIN28A and LIN28B genes are ex-
pressed predominantly in undifferentiated cells, such as em-
bryonic stem cells (ESCs), and primarily function to repress
let-7 miRNA expression thereby relieving repression of let-7
target mRNAs, and possibly also function to regulate mRNA
translation and/or splicing by unknown mechanisms (Pole-
sskaya et al., 2007; Wilbert et al., 2012). LIN28 proteins contain
a cold-shock domain (CSD) and two CCHC-type zinc-finger
domains that bind respectively to the GNGAY consensus
sequence (Y, pyrimidine; N, any base) in the let-7 preE loop
and a conserved GGAG motif in the let-7 preE bulge (Ali
et al., 2012; Heo et al., 2009; Loughlin et al., 2012; Mayr
et al., 2012; Nam et al., 2011; Piskounova et al., 2008).
LIN28A and LIN28B are predominantly cytoplasmic and nu-
clear, respectively, and repress let-7 biogenesis by two dis-
tinct mechanisms. LIN28A recruits ZCCHC6 and ZCCHC11,
which catalyze 30 oligo-uridylation of pre-let-7 miRNA (Hagan
et al., 2009; Heo et al., 2009; Thornton et al., 2012). This
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D Figure 1. Systematic Analysis of Let-7 Re-
gulation by LIN28 Proteins
(A) Western blot analyses show expression of
FLAG-LIN28A and FLAG-LIN28B upon doxycyline
treatment.
(B and C) The qRT-PCR analyses of let-7 expres-
sion in iLIN28A (B) and iLIN28B HeLa cells (C).
Results are the average of two biological replicate
experiments represented as the percentage of
repression relative to mock-treated cells. Error
bars represent SD.
(D) Electrophoretic mobility shift assay (EMSA)
showing relative LIN28A binding to individual pre-
let-7 RNAs. A 2-fold dilution series was used for
the LIN28A titrations. Human precursors were
used in these assays unless stated otherwise. See
also Figure S1.modification inhibits Dicer processing and induces 30–50 de-
gradation of let-7 precursors by the DIS3L2 exonuclease
(Chang et al., 2013; Faehnle et al., 2014; Ustianenko et al.,
2013). LIN28B binds let-7 preE in the nucleus and blocks
Microprocessor-mediated cleavage of pri-let-7 miRNA by an
unknown mechanism (Piskounova et al., 2011).
The LIN28/let-7 axis profoundly impacts diverse biological
processes in mammals, including stem cell pluripotency, devel-
opment, glucose metabolism, tissue regeneration, organismal
growth, and the ages of onset of menopause and puberty in
humans (Shyh-Chang and Daley, 2013; Shyh-Chang et al.,
2013; Thornton and Gregory, 2012; Viswanathan and Daley,
2010). This embryonic pathway is frequently reactivated in hu-
man cancers, correlates with poor patient survival, and is suffi-
cient to drive tumorigenesis in cell and mouse cancer models
(Diskin et al., 2012; Madison et al., 2013; Molenaar et al.,
2012; Nguyen et al., 2014; Thornton and Gregory, 2012; Urbach
et al., 2014; Viswanathan et al., 2009). Importantly, where
examined, the regulation of let-7 plays a central role in these
numerous biological functions of LIN28A and LIN28B. While it
has been widely appreciated that these RNA-binding proteins
coordinately inhibit let-7 miRNA biogenesis, a systematic anal-
ysis and comparison of all let-7 miRNAs has not yet been per-
formed. Here we find that, although LIN28A and LIN28B exert a
similar degree of repression on different let-7 miRNAs, a spe-
cific let-7 member, human let-7a-3 (and its murine ortholog
let-7c-2), bypasses LIN28-mediated blockade both in vitro
and in human cancer cells and mouse ESCs (mESCs). We
furthermore provide mechanistic insight into this escape from
LIN28-mediated regulation.
RESULTS
Analysis of Let-7 Regulation by LIN28 Proteins
To compare the repressive activity of LIN28 proteins on let-7, we
generated doxycycline-inducible HeLa cell lines, which do notCell Reports 13, 260–266,have detectable expression of endoge-
nous LIN28A and LIN28B and conversely
express high levels of all let-7 isoforms
(Heo et al., 2012; Piskounova et al.,2011; Thornton et al., 2014). Isogenic clones expressing either
FLAG-LIN28A (iLIN28A) or FLAG-LIN28B (iLIN28B) were ob-
tained. Upon doxycycline treatment, each protein was ex-
pressed to a comparable level by western blot and displayed a
typical localization pattern as reported before (Figures 1A and
S1A; Hafner et al., 2010; Piskounova et al., 2011). Of note, this
system achieved respectively lower and higher expression levels
of LIN28A and LIN28B compared to human ESCs and a similar
expression level for LIN28B compared to a panel of LIN28B-ex-
pressing human cancer cell lines, indicating that these isogenic
clones express LIN28A/B at physiologically relevant levels (Fig-
ures S1B and S1C).
Next, we examined the relative expression of different let-7
miRNAs upon LIN28A or LIN28B induction by qRT-PCR. Ex-
amination of let-7 levels showed a specific reduction of each
let-7 isoform 2 days after doxycycline treatment (Figures 1B,
1C, and S1D). Although LIN28 proteins inhibit let-7 biogenesis
by different mechanisms (Piskounova et al., 2011), a com-
parable degree of let-7 repression was observed between
LIN28A and LIN28B. Therefore, LIN28 proteins achieve the
same role in regulating let-7 expression. We also noticed
that different let-7 isoforms were downregulated to variable
degrees after LIN28 protein induction, ranging from <30%
for let-7a to >70% for most other isoforms (Figures 1B and
1C). While this qRT-PCR analysis could not distinguish among
the three let-7a miRNAs expressed from different loci (let-
7a-1, let-7a-2, and let-7a-3), it suggests that one or more of
let-7a miRNA isoforms might be differentially sensitive to
LIN28 repression. We hypothesized that LIN28 proteins might
bind these isoforms with different affinities, and we chose to
systematically investigate LIN28A binding to each of the 12
human let-7 precursors by electrophoretic mobility shift as-
says (EMSAs). Our analysis revealed that one pre-let-7 iso-
form, namely, pre-let-7a-3, binds LIN28A and LIN28B with a
much lower affinity than the other pre-let-7 members. Mouse
pre-let-7c-2, which is orthologous to human pre-let-7a-3,October 13, 2015 ª2015 The Authors 261
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Figure 2. Human Let-7a-3 and Mouse Let-
7c-2 Bypass LIN28A-Mediated Repression
(A) The qRT-PCR analyses of let-7g, let-7a, and let-
7c expression in HeLa cells upon transfection of
empty vectors (mock), let-7 pri-miRNA only, or let-7
pri-miRNA and FLAG-LIN28A, as indicated, are
shown.
(B) Schematic representation of the let-7c-2 locus.
Arrowheads indicate guide RNA (gRNA) target sites
used for CRISPR/Cas9 DNA editing.
(C) PCR for genotyping analysis of let-7c-2+/+ and
let-7c-2/ TC1 mESC clones is shown.
(D) Sequencing analyses showing the deletion in the
let-7c-2 locus. The upper track and the lower track
correspond to the sequencing results obtained from
the let-7c-2+/+ clone 1 and the let-7c-2/ clone 1,
respectively.
(E) The qRT-PCR analyses for let-7c expression in
let-7c-2+/+ and let-7c-2/ clones are shown.
(F) The qRT-PCR analyses for let-7g and let-7c
expression in KH2-iLIN28A mESCs treated with or
without doxycycline (dox) are shown.
(G) The qRT-PCR analyses for let-7g and let-7c
expression in TC1 mESCs transfected with control
or Lin28a siRNA. Western blot results validate
LIN28A knockdown (top right). For (A) and (E)–(G),
results are the average of two independent experi-
ments. Error bars represent SD.also displayed a strikingly lower affinity for LIN28 binding (Fig-
ures 1D, S1E, and S1F).
A Single Let-7 Isoform Bypasses LIN28A Regulation
Considering the in vitro binding data, we next asked whether
these let-7 isoforms could be repressed by LIN28 in cells.
We individually overexpressed pri-let-7g, pri-let-7a-3, or pri-
let-7c-2 in HeLa cells in the presence or absence of LIN28A
and measured the corresponding mature let-7 miRNA levels by
qRT-PCR (Figure 2A). While let-7g was strongly repressed
(more than 80%) by LIN28A, we did not detect any significant
change in the expression of let-7a and let-7c upon LIN28A over-
expression, thereby indicating that let-7a-3 and let-7c-2 iso-
forms can bypass LIN28A-mediated repression.
We also evaluated this bypass mechanism in mESCs by
examining endogenous let-7c expression. The mouse genome
encodes for two let-7c isoforms, namely, let-7c-1 and let-
7c-2, which cannot be distinguished by qRT-PCR analyses
since the mature let-7 miRNA sequences are identical. Upon
deletion of the let-7c-2 locus using the CRISPR/Cas9 ge-
nome-editing system, we found that let-7c expression was
lost in let-7c-2/ mouse ESCs, suggesting that let-7c-2 is
the most abundant let-7c isoform expressed in these cells
(Figures 2B–2E). We found that, while let-7g levels were sub-
stantially suppressed by LIN28A overexpression in mESCs,
the levels of let-7c were unaffected (Figure 2F). Similarly, let-262 Cell Reports 13, 260–266, October 13, 2015 ª2015 The Authors7g levels accumulated upon LIN28A
knockdown whereas let-7c levels re-
mained unchanged (Figure 2G). There-
fore, physiological expression of LIN28A
in cells does not impact endogenouslet-7c-2 expression. Altogether, these results show that, unlike
all other let-7 miRNAs, a single member (mouse let-7c-2 and
human let-7a-3) escapes LIN28 binding and regulation.
The preE Loop in Pre-let-7c-2 Precludes LIN28ABinding
We sought to address at the molecular level how pre-let-7c-2
might escape the LIN28 blockade. We noticed that let-7c-2
precursor lacks the canonical GGAG motif in the preE bulge
(Figure 3A). We postulated that restoring this motif would
be sufficient to confer LIN28A binding and regulation. We per-
formed mutagenesis to substitute the atypical UGCG motif
within the pre-let-7c-2 preE bulge with a canonical GGAG
motif found in most other pre-let-7 family members. To
our surprise, we observed that addition of the GGAG seq-
uence was not sufficient to restore LIN28A binding to the
mutated pre-let-7c-2 (Figures 3A and 3B). Accordingly, pre-
let-7c-2 containing GGAG was not appreciably suppressed
by LIN28A expression in transfected cells (Figure 3C). Con-
sidering these results, we also replaced the GGAG motif
in let-7g preE with UGCG (i.e., the sequence from pre-let-
7c-2), and we did not observe any dramatic differences in
LIN28A binding to or repression of this let-7g mutant. These
data suggest that the UGCG motif is functional and that
another sequence and/or structural features of pre-let-7c-2
are responsible for the escape from LIN28 regulation (Figures
3A–3C).
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Figure 3. The preE Loop of Pre-let-7c-2 Precludes LIN28A Binding
and Regulation
(A) Representation of different wild-type and mutant preE sequences of let-7
constructs used in EMSA and transfection experiments. Mutations are un-
derlined, preE stem is in blue, and GGAG motif is in red.
(B) EMSA shows specific binding of LIN28A to individual let-7 wild-type and
mutant pre-miRNA depicted in (A).
(C) The qRT-PCR analyses of let-7a, let-7c, and let-7g expression in HeLa cells
upon transfection of empty vectors (mock), let-7 pri-miRNA only, or let-7 pri-
miRNA and FLAG-LIN28A, as indicated. Results are the average of two in-
dependent experiments. Error bars represent SD.We considered that the terminal loop of the preE of pre-let-7c-
2 might inhibit LIN28 binding. To explore this, we generated a
mutant form of pre-let-7c-2 by substituting nucleotides in the
preE loop with corresponding nucleotides from the let-7a-1
preE loop, which shares a very comparable structure and yet in-
teracts with and is regulated by LIN28A. A 5-nt substitution
comprising the pre-let-7c-2 preE loop with the stem-loop junc-
tion (CUCUG > UCACA) was sufficient to rescue LIN28A binding
in EMSA (Figures 3A and 3B). EMSA performed with additional
mutations within this region revealed that that the 5-nt change
is necessary and sufficient to confer LIN28 binding in the context
of pre-let-7c-2 (Figure 3B). LIN28A-mediated repression also
was established by this terminal loop replacement (Figure 3C).
Therefore, these results strongly suggest that let-7c-2 bypasses
LIN28A repression primarily because the interaction between the
LIN28A CSD and the let-7c-2 preE loop is compromised.CDISCUSSION
By performing a systematic analysis of all 12 let-7 miRNAs, we
surprisingly found that a single let-7 family member, namely,
let-7a-3 in human and let-7c-2 in mouse, escapes LIN28-medi-
ated regulation. Using both EMSA to measure relative LIN28-
binding affinities to different pre-let-7 family members, as well
as measuring let-7 miRNA levels in response to LIN28A or
LIN28B overexpression and LIN28A knockdown in cells, we
conclude that these two miRNA precursors are refractory to
LIN28 binding and regulation. Although previous analyses
have examined the global effects of LIN28 gain- or loss-of-
function on miRNA expression, these studies failed to appre-
ciate that not all let-7 miRNAs are regulated by these proteins
(Hagan et al., 2009; Newman et al., 2008), and they contributed
to the current dogma that LIN28 proteins coordinately repress
let-7 expression. This finding likely remained obscure because
both let-7c in mouse and let-7a in human are expressed from
multiple different loci (i.e., let-7c-1 and let-7c-2 [mouse] and
let-7a-1, let-7a-2, and let-7a-3 [human]). Since the mature
miRNA sequence within each subfamily is identical, it is not
possible to distinguish them by qRT-PCR, microarray, or RNA
sequencing, thereby confounding the interpretation of miRNA
expression studies.
Mechanistically, we found that the 5-nt-long sequence for-
ming the short apical stem-loop of let-7c-2 preE precludes
LIN28A binding in vitro and LIN28A-mediated repression in cells.
In fact, replacing this sequence with the corresponding nucleo-
tides from the pre-let-7a-1 preE loop substantially restored
LIN28A interaction. This interaction might result from the
combined effect of the following: (1) creating a more favorable
CSD-binding motif; and (2) weakening the base pairing in the
stem by changing a G-C pair to an A-U pair, thus allowing
the CSD to protrude through the terminal loop and remodel the
base pairing in the stem. Our results also suggest that the lack
of a canonical GGAG motif in let-7c-2 preE bulge was not
responsible for the bypass. Indeed, swapping the respective
GGAG and UGCG motifs in pre-let-7g and pre-let-7c-2 did not
have a significant impact on the interaction or lack of interaction
with LIN28A. These results are in accordance with a previous
study, where it was proposed that LIN28 CSD binds first to
let-7 preE and remodels its structure to allow for subsequent
binding of the GGAG motif by LIN28 CCHC-type zinc fingers in
order to anchor the protein to the precursor RNA (Mayr et al.,
2012).
It will be interesting to explore the full range of physiological
contexts where that bypass is relevant. Mouse models with let-
7c-2 deletion will help dissect the importance of this mechanism.
Since LIN28A and LIN28BmRNAs both contain let-7 target sites
and are repressed in let-7-expressing cells, it is tempting to
speculate that this LIN28 bypassmight be important for resetting
the bistable switch to alter cell fate decisions. Related to this,
the efficiency of reprogramming mouse embryonic fibroblasts
(MEFs) to induced pluripotent stem cells (iPSCs) was more
substantially enhanced by let-7 antisense oligonucleotides
(that should antagonize all let-7 members) than by ectopic
LIN28 expression (Worringer et al., 2014). It will be important to
understand which cell types and developmental stages expressell Reports 13, 260–266, October 13, 2015 ª2015 The Authors 263
high levels of these individual let-7 miRNAs and the upstream
mechanisms controlling their transcription (Patterson et al.,
2014). Given also the strong links between let-7 repression and
tumorigenesis, it also will be interesting to explore the epige-
netic/genetic loss of let-7a-3. In this regard, deletions containing
the let-7a-3/let-7b locus have been reported in human tumors
(Wang et al., 2012). Our results also predict that epigenetic/ge-
netic loss of let-7a-3would cooperate with the oncogenic effects
of LIN28A and LIN28B activation in human tumorigenesis.
Intriguingly, it was recently demonstrated in a mouse model
that conditional deletion of the let-7c-2/let-7b locus functionally
cooperates with transgenic Lin28b overexpression to drive hy-
perplasia of the intestinal epithelium (Madison et al., 2013,
2015). Our mechanistic studies can help explain this result and
will likely provoke future studies that address the relative contri-
bution of this newly identified mechanism in the many different
contexts where the LIN28/let-7 axis is known to be important.EXPERIMENTAL PROCEDURES
DNA Cloning and Mutagenesis
Human LIN28A and LIN28B cDNA were PCR amplified from pFLAG-CMV2
LIN28A and pFLAG-CMV2 LIN28B, respectively (Piskounova et al., 2011),
and cloned into pcDNA5/FRT/TO vector (Invitrogen). Human and mouse pri-
let-7 cDNA were PCR amplified from HeLa cells and J1 ESC genomic
DNA, respectively, and cloned into pcDNA3 vector. Pri-let-7 mutant plasmids
were generated by site-directed mutagenesis using QuikChange II Site-
Directed Mutagenesis kit (Agilent Technologies). For CRISPR/Cas9-mediated
Let-7c-2 gene editing, oligonucleotides were designed online (http://crispr.
mit.edu/), annealed, and cloned into BbsI site of pX330 vector (see Table S1
for oligonucleotide sequences).
Transfection
Plasmids and small interfering RNA (siRNA) transfections were performed
with Lipofectamine 2000 (Invitrogen). The mESCs were transfected by re-
verse transfection with the following synthetic RNA (all from Dharmacon):
ON-TARGETplus Non-targeting Pool (D-001810-10-20) and ON-TARGETplus
Mouse Lin28a (83557) siRNA–SMARTpool (L-051530-01-0020).
Cell Culture
HeLa, HEK293T, HepG2, and H1299 cell lines were maintained in DMEM
(Gibco) supplemented with penicillin/streptomycin (Gibco) and 10% fetal
bovine serum (Gemini Bio Products). K562 cells were maintained in RPMI
medium (Gibco) supplemented with penicillin/streptomycin and 10% fetal
bovine serum. Flp-In T-REx HeLa cells (a kind gift of Stephen Taylor, Univer-
sity of Manchester) were maintained in DMEM supplemented with penicillin/
streptomycin, 4 mg/ml blasticidin (Gibco), 50 mg/ml zeocin (Gibco), and 10%
fetal bovine serum. Flp-In T-REx iLIN28A and iLIN28B HeLa cells were gener-
ated by cotransfecting pcDNA5/FRT/TO FLAG-LIN28A or pcDNA5/FRT/TO
FLAG-LIN28B vector with the Flp recombinase-encoding plasmid pOG44
(Invitrogen). Isogenic clones were isolated and maintained in DMEM sup-
plemented with penicillin/streptomycin, 4 mg/ml blasticidin, 200 mg/ml hy-
gromycin (Sigma), and 10%Tet SystemApproved fetal bovine serum (Clontech
Laboratories). Transgene expression was assayed upon treatment with 1 mg/ml
doxycycline (Sigma) for 48 hr. TC1mESCswere cultured feeder-free on gelatin-
coated dishes with KO-DMEM medium (Gibco) supplemented with 15% fetal
bovine serum (Gemini Bio Products), L-glutamine (Gibco), sodium pyruvate
(Gibco), non-essential amino acids (Gibco), 2-mercaptoethanol, penicillin/
streptomycin, and 1,000 U/ml LIF (Gemini Bio Products) that is referred to as
LIF/serum condition. For CRIPSR/Cas9-mediated gene manipulation of TC1
cells and for KH2 iFLAG-Lin28A mESC culture, cells were propagated in LIF/
2i condition, consisting of N2B27 medium supplemented with LIF as well as
3 mM CHIR99021 (Stemgent) and 1 mM PD0325901 (Stemgent).264 Cell Reports 13, 260–266, October 13, 2015 ª2015 The AuthorsCRISPR/Cas9-Mediated Gene Editing
TC1 mESCs were cotransfected by nucleofection (Lonza) with 1 mg of each
pX330 vector encoding for let-7c-2-specific guide RNA 1 and 2 and 0.1 mg vec-
tor for expression of puromycin resistance gene. Then, 1 day later, 2.5 mg/ml
puromycin (Sigma) was added to the media for 24 hr. Individual mESC clones
were isolated and genotyped by PCR and Sanger sequencing.
EMSA
PCR amplification of pri-let-7 expression plasmids was used to generate
DNA templates for in vitro transcription of radiolabeled pre-let-7 RNA (see
Table S1 for oligonucleotide sequences). These DNA templates were gel-pu-
rified and in vitro transcription was performed according to Riboprobe
In Vitro Transcription Systems (Promega) using [a-32P] rUTP and T7 RNA po-
lymerase. Radiolabeled pre-let-7 RNAs subsequently were treated with RQ1
DNase and purified using Illustra MicroSpin G-25 Columns (GE Healthcare).
For EMSA, reactions were set up in binding buffer (50 mM Tris [pH 7.6],
100 mM NaCl, 10 mM 2-mercaptoethanol, and 1 U/ml rRNasin [Promega])
with radiolabelled RNA and varying amounts of immunopurified FLAG-
LIN28A or FLAG-LIN28B proteins and incubated for 30 min at room temper-
ature. Protein-RNA complexes were resolved on native 5% polyacrylamide
gels and visualized by autoradiography.
Real-Time PCR
Total RNA was isolated with TRIzol reagent (Invitrogen) and reverse tran-
scribed using TaqMan MicroRNA Reverse Transcription Kit (Applied Bio-
systems). Real-time PCR was performed using individual TaqMan Assays
(Applied Biosystems) with TaqMan universal PCR master mix, no AmpErase
UNG (Applied Biosystems). Gene expression was normalized to U6 small nu-
clear RNA (snRNA).
Antibodies
For western blot and immunocytochemistry analyses, the following antibodies
were used: anti-FLAG (Sigma, A8592), anti-LIN28A (A177) (Cell Signaling
Technology, 3978), anti-LIN28B (Cell Signaling Technology, 4196), anti-
OCT4 (Abcam, ab19857), anti-ACTIN (Sigma, A2066), and anti-beta TUBULIN
(Abcam, ab6046).
SUPPLEMENTAL INFORMATION
Supplemental Information includes one figure and one table and can be found
with this article online at http://dx.doi.org/10.1016/j.celrep.2015.08.086.
AUTHOR CONTRIBUTIONS
R.T. performed all experiments. M.P. helped generate let-7c-2/ mESCs us-
ing CRISPR/Cas9 technology. R.T. and R.I.G. designed all experiments,
analyzed data, and wrote the manuscript with helpful discussion with M.P.
ACKNOWLEDGMENTS
We thank Dr. Stephen Taylor (University of Manchester) for Flp-In T-REx Hela
cells. This work was supported by a grant to R.I.G. from the U.S. National Insti-
tute of General Medical Sciences (NIGMS) (R01GM086386).
Received: April 28, 2015
Revised: August 12, 2015
Accepted: August 31, 2015
Published: October 1, 2015
REFERENCES
Ali, P.S., Ghoshdastider, U., Hoffmann, J., Brutschy, B., and Filipek, S. (2012).
Recognition of the let-7g miRNA precursor by human Lin28B. FEBS Lett. 586,
3986–3990.
Ambros, V., and Horvitz, H.R. (1984). Heterochronic mutants of the nematode
Caenorhabditis elegans. Science 226, 409–416.
B€ussing, I., Slack, F.J., and Grosshans, H. (2008). let-7 microRNAs in develop-
ment, stem cells and cancer. Trends Mol. Med. 14, 400–409.
Chang, H.M., Triboulet, R., Thornton, J.E., and Gregory, R.I. (2013). A role for
the Perlman syndrome exonuclease Dis3l2 in the Lin28-let-7 pathway. Nature
497, 244–248.
Denli, A.M., Tops, B.B., Plasterk, R.H., Ketting, R.F., and Hannon, G.J. (2004).
Processing of primary microRNAs by the Microprocessor complex. Nature
432, 231–235.
Diskin, S.J., Capasso, M., Schnepp, R.W., Cole, K.A., Attiyeh, E.F., Hou, C.,
Diamond, M., Carpenter, E.L., Winter, C., Lee, H., et al. (2012). Common vari-
ation at 6q16 within HACE1 and LIN28B influences susceptibility to neuroblas-
toma. Nat. Genet. 44, 1126–1130.
Faehnle, C.R., Walleshauser, J., and Joshua-Tor, L. (2014). Mechanism of
Dis3l2 substrate recognition in the Lin28-let-7 pathway. Nature 514, 252–256.
Gregory, R.I., Yan, K.P., Amuthan, G., Chendrimada, T., Doratotaj, B., Cooch,
N., and Shiekhattar, R. (2004). TheMicroprocessor complexmediates the gen-
esis of microRNAs. Nature 432, 235–240.
Hafner, M., Landthaler, M., Burger, L., Khorshid, M., Hausser, J., Berninger, P.,
Rothballer, A., Ascano, M., Jr., Jungkamp, A.C., Munschauer, M., et al. (2010).
Transcriptome-wide identification of RNA-binding protein and microRNA
target sites by PAR-CLIP. Cell 141, 129–141.
Hagan, J.P., Piskounova, E., and Gregory, R.I. (2009). Lin28 recruits the
TUTase Zcchc11 to inhibit let-7 maturation in mouse embryonic stem cells.
Nat. Struct. Mol. Biol. 16, 1021–1025.
Heo, I., Joo, C., Cho, J., Ha, M., Han, J., and Kim, V.N. (2008). Lin28 mediates
the terminal uridylation of let-7 precursor MicroRNA. Mol. Cell 32, 276–284.
Heo, I., Joo, C., Kim, Y.K., Ha, M., Yoon, M.J., Cho, J., Yeom, K.H., Han, J.,
and Kim, V.N. (2009). TUT4 in concert with Lin28 suppresses microRNA
biogenesis through pre-microRNA uridylation. Cell 138, 696–708.
Heo, I., Ha, M., Lim, J., Yoon, M.J., Park, J.E., Kwon, S.C., Chang, H., and Kim,
V.N. (2012). Mono-uridylation of pre-microRNA as a key step in the biogenesis
of group II let-7 microRNAs. Cell 151, 521–532.
Loughlin, F.E., Gebert, L.F., Towbin, H., Brunschweiger, A., Hall, J., and Allain,
F.H. (2012). Structural basis of pre-let-7 miRNA recognition by the zinc
knuckles of pluripotency factor Lin28. Nat. Struct. Mol. Biol. 19, 84–89.
Madison, B.B., Liu, Q., Zhong, X., Hahn, C.M., Lin, N., Emmett, M.J., Stanger,
B.Z., Lee, J.S., and Rustgi, A.K. (2013). LIN28B promotes growth and tumor-
igenesis of the intestinal epithelium via Let-7. Genes Dev. 27, 2233–2245.
Madison, B.B., Jeganathan, A.N., Mizuno, R., Winslow, M.M., Castells, A.,
Cuatrecasas, M., and Rustgi, A.K. (2015). Let-7 Represses Carcinogenesis
and a Stem Cell Phenotype in the Intestine via Regulation of Hmga2. PLoS
Genet. 11, e1005408.
Mayr, F., Sch€utz, A., Do¨ge, N., and Heinemann, U. (2012). The Lin28 cold-
shock domain remodels pre-let-7 microRNA. Nucleic Acids Res. 40, 7492–
7506.
Michlewski, G., and Ca´ceres, J.F. (2010). Antagonistic role of hnRNP A1 and
KSRP in the regulation of let-7a biogenesis. Nat. Struct. Mol. Biol. 17, 1011–
1018.
Molenaar, J.J., Domingo-Ferna´ndez, R., Ebus, M.E., Lindner, S., Koster, J.,
Drabek, K., Mestdagh, P., van Sluis, P., Valentijn, L.J., van Nes, J., et al.
(2012). LIN28B induces neuroblastoma and enhances MYCN levels via let-7
suppression. Nat. Genet. 44, 1199–1206.
Moss, E.G., and Tang, L. (2003). Conservation of the heterochronic regulator
Lin-28, its developmental expression and microRNA complementary sites.
Dev. Biol. 258, 432–442.
Moss, E.G., Lee, R.C., and Ambros, V. (1997). The cold shock domain protein
LIN-28 controls developmental timing in C. elegans and is regulated by the lin-
4 RNA. Cell 88, 637–646.
Nam, Y., Chen, C., Gregory, R.I., Chou, J.J., and Sliz, P. (2011). Molecular
basis for interaction of let-7 microRNAs with Lin28. Cell 147, 1080–1091.CNewman,M.A., Thomson, J.M., and Hammond, S.M. (2008). Lin-28 interaction
with the Let-7 precursor loop mediates regulated microRNA processing. RNA
14, 1539–1549.
Nguyen, L.H., Robinton, D.A., Seligson, M.T., Wu, L., Li, L., Rakheja, D.,
Comerford, S.A., Ramezani, S., Sun, X., Parikh, M.S., et al. (2014). Lin28b is
sufficient to drive liver cancer and necessary for its maintenance in murine
models. Cancer Cell 26, 248–261.
Pasquinelli, A.E., Reinhart, B.J., Slack, F., Martindale, M.Q., Kuroda, M.I.,
Maller, B., Hayward, D.C., Ball, E.E., Degnan, B., M€uller, P., et al. (2000). Con-
servation of the sequence and temporal expression of let-7 heterochronic reg-
ulatory RNA. Nature 408, 86–89.
Patterson, M., Gaeta, X., Loo, K., Edwards, M., Smale, S., Cinkornpumin, J.,
Xie, Y., Listgarten, J., Azghadi, S., Douglass, S.M., et al. (2014). let-7 miRNAs
can act through notch to regulate human gliogenesis. Stem Cell Reports 3,
758–773.
Piskounova, E., Viswanathan, S.R., Janas, M., LaPierre, R.J., Daley, G.Q., Sliz,
P., and Gregory, R.I. (2008). Determinants of microRNA processing inhibition
by the developmentally regulated RNA-binding protein Lin28. J. Biol. Chem.
283, 21310–21314.
Piskounova, E., Polytarchou, C., Thornton, J.E., LaPierre, R.J., Pothoulakis,
C., Hagan, J.P., Iliopoulos, D., and Gregory, R.I. (2011). Lin28A and Lin28B
inhibit let-7 microRNA biogenesis by distinct mechanisms. Cell 147, 1066–
1079.
Polesskaya, A., Cuvellier, S., Naguibneva, I., Duquet, A., Moss, E.G., and
Harel-Bellan, A. (2007). Lin-28 binds IGF-2 mRNA and participates in skel-
etal myogenesis by increasing translation efficiency. Genes Dev. 21, 1125–
1138.
Reinhart, B.J., Slack, F.J., Basson, M., Pasquinelli, A.E., Bettinger, J.C., Roug-
vie, A.E., Horvitz, H.R., and Ruvkun, G. (2000). The 21-nucleotide let-7 RNA
regulates developmental timing in Caenorhabditis elegans. Nature 403,
901–906.
Roush, S., and Slack, F.J. (2008). The let-7 family of microRNAs. Trends Cell
Biol. 18, 505–516.
Rybak, A., Fuchs, H., Smirnova, L., Brandt, C., Pohl, E.E., Nitsch, R., andWulc-
zyn, F.G. (2008). A feedback loop comprising lin-28 and let-7 controls pre-let-7
maturation during neural stem-cell commitment. Nat. Cell Biol. 10, 987–993.
Shyh-Chang, N., and Daley, G.Q. (2013). Lin28: primal regulator of growth and
metabolism in stem cells. Cell Stem Cell 12, 395–406.
Shyh-Chang, N., Zhu, H., Yvanka de Soysa, T., Shinoda, G., Seligson, M.T.,
Tsanov, K.M., Nguyen, L., Asara, J.M., Cantley, L.C., and Daley, G.Q.
(2013). Lin28 enhances tissue repair by reprogramming cellular metabolism.
Cell 155, 778–792.
Thornton, J.E., andGregory, R.I. (2012). How does Lin28 let-7 control develop-
ment and disease? Trends Cell Biol. 22, 474–482.
Thornton, J.E., Chang, H.M., Piskounova, E., and Gregory, R.I. (2012). Lin28-
mediated control of let-7 microRNA expression by alternative TUTases
Zcchc11 (TUT4) and Zcchc6 (TUT7). RNA 18, 1875–1885.
Thornton, J.E., Du, P., Jing, L., Sjekloca, L., Lin, S., Grossi, E., Sliz, P., Zon, L.I.,
andGregory, R.I. (2014). SelectivemicroRNA uridylation by Zcchc6 (TUT7) and
Zcchc11 (TUT4). Nucleic Acids Res. 42, 11777–11791. http://dx.doi.org/10.
1093/nar/gku805.
Trabucchi, M., Briata, P., Garcia-Mayoral, M., Haase, A.D., Filipowicz, W., Ra-
mos, A., Gherzi, R., and Rosenfeld, M.G. (2009). The RNA-binding protein
KSRP promotes the biogenesis of a subset of microRNAs. Nature 459,
1010–1014.
Urbach, A., Yermalovich, A., Zhang, J., Spina, C.S., Zhu, H., Perez-Atayde,
A.R., Shukrun, R., Charlton, J., Sebire, N., Mifsud, W., et al. (2014). Lin28 sus-
tains early renal progenitors and induces Wilms tumor. Genes Dev. 28,
971–982.
Ustianenko, D., Hrossova, D., Potesil, D., Chalupnikova, K., Hrazdilova, K., Pa-
chernik, J., Cetkovska, K., Uldrijan, S., Zdrahal, Z., and Vanacova, S. (2013).
Mammalian DIS3L2 exoribonuclease targets the uridylated precursors of
let-7 miRNAs. RNA 19, 1632–1638.ell Reports 13, 260–266, October 13, 2015 ª2015 The Authors 265
Viswanathan, S.R., and Daley, G.Q. (2010). Lin28: A microRNA regulator with a
macro role. Cell 140, 445–449.
Viswanathan, S.R., Daley, G.Q., and Gregory, R.I. (2008). Selective blockade
of microRNA processing by Lin28. Science 320, 97–100.
Viswanathan, S.R., Powers, J.T., Einhorn, W., Hoshida, Y., Ng, T.L., Toffanin,
S., O’Sullivan, M., Lu, J., Phillips, L.A., Lockhart, V.L., et al. (2009). Lin28 pro-
motes transformation and is associated with advanced human malignancies.
Nat. Genet. 41, 843–848.
Wang, Y., Hu, X., Greshock, J., Shen, L., Yang, X., Shao, Z., Liang, S., Tanyi,
J.L., Sood, A.K., and Zhang, L. (2012). Genomic DNA copy-number alterations
of the let-7 family in human cancers. PLoS ONE 7, e44399.266 Cell Reports 13, 260–266, October 13, 2015 ª2015 The AuthorsWilbert, M.L., Huelga, S.C., Kapeli, K., Stark, T.J., Liang, T.Y., Chen, S.X., Yan,
B.Y., Nathanson, J.L., Hutt, K.R., Lovci, M.T., et al. (2012). LIN28 binds
messenger RNAs at GGAGA motifs and regulates splicing factor abundance.
Mol. Cell 48, 195–206.
Worringer, K.A., Rand, T.A., Hayashi, Y., Sami, S., Takahashi, K., Tanabe, K.,
Narita, M., Srivastava, D., and Yamanaka, S. (2014). The let-7/LIN-41 pathway
regulates reprogramming to human induced pluripotent stem cells by control-
ling expression of prodifferentiation genes. Cell Stem Cell 14, 40–52.
Zhang, P., Elabd, S., Hammer, S., Solozobova, V., Yan, H., Bartel, F., Inoue, S.,
Henrich, T., Wittbrodt, J., Loosli, F., et al. (2015). TRIM25 has a dual function in
the p53/Mdm2 circuit. Oncogene.
